US stocks mostly lower; Nasdaq down 50 points – Dermata Therapeutics…

US stocks mostly lower; Nasdaq down 50 points – Dermata Therapeutics…

Facebook
Twitter
LinkedIn

US stocks were mostly trading lower this morning, with the Nasdaq Composite falling around 50 points on Friday.

After Friday’s market open, the Dow fell 0.03% to 33,777.38, while the NASDAQ fell 0.43% to 12,008.96. The S&P 500 was also down 0.18% to 4,122.44.

Look at that: Top 4 Technology & Telecom Stocks That Could Dip In Q2

Leading and lagging sectors

  • Shares in consumer staples rose 0.7% on Friday. Meanwhile top winner in the sector included Steakholder Foods Ltd. STKHup to 5% and The Procter & Gamble company PGplus 4%.
  • Information technology shares fell 0.9% in Friday trading.

top heading

The S&P Global US Manufacturing PMI rose to 50.4 in April from 49.2 the previous month, beating the market estimate of 49. The S&P Global Composite PMI rose to 53.5 in April from 52.3 a month ago.

Stock trading UP

  • Wang & Lee Group, Inc. WLGS Shares soared 43% to $4.44 after falling 38% on Thursday. WANG & LEE GROUP has offered its IPO of 1,600,000 shares at a price of $5.00 per share.
  • shares of ContextLogic Inc. WISH got a boost, rising 39% to $9.95 after the company announced a $50 million buyback program.
  • EyePoint Pharmaceuticals, Inc. EYPT Shares were also higher, gaining 35% to $7.67 after Baird began reporting on the stock with an Outperform rating and a $33 price target.

Stocks are trading down

  • U Power Limited UCAR Shares fell 40% to $25.70initial public offering Volatility. U Power priced its IPO at $6 per share with 2,416,667 shares.
  • shares of Ocuphire Pharma, Inc. OKUP was down 20% to $4.9350 after the company appointed Rick Rodgers as interim CEO and President.
  • Dermata Therapeutics, Inc. DRMA fell 11% to $2.54.
  • Dermata Therapeutics announced Thursday that it has received a response from the FDA regarding its Type C CMC meeting. The FDA’s response states that the company has provided documentation of its CMC procedures and controls sufficient to support the initiation of Phase 3…

[ad_2]

Source story

More to explorer